Abstract
Two series of 17 tetrahydroquinoline compounds (2,4-DAr-THQs and DSQs), in which the 4-methoxy-3- hydroxyphenyl (isovanillin) structural unit is incorporated, were tested for their potential human tumor cell growth inhibitory effect on MCF-7, SKBR-3, PC3, HeLa and for non-tumor cells (primary culture of human dermis fibroblast – control cells) for the first time. The THQ 8 is an interesting model for antitumoral drugs, displaying cytotoxic activity against MCF7, SKBR3 or PC3 (IC50 7.99 - 16.14 μM) with the selectivity index 3.4 for MCF7.
Keywords: Functionalized tetrahydroquinolines, Isoeugenol, Antitumoral agents, Lewis acid-catalyzed imino Diels-Alder reactions, Tetrahydroquinoline compounds, Antimalarial, Antioxidant, Antimycobacterial, Polyfunctionalized quinoline, Anticancer agents, Hemi-synthetic, Synthetiq agents, Imino Diels Alder cycloaddition, Ketimine precursors, HeLa (cervical epithelial carcinoma), Adriamycin, Eugenol, Quinoline derivatives, Cytotoxic activities, Tumor cancer cells, Isatin, Anilines, Reference selectivity index
Letters in Drug Design & Discovery
Title: 4-Hydroxy-3-methoxyphenyl Substituted 3-methyl-tetrahydroquinoline Derivatives Obtained Through Imino Diels-Alder Reactions as Potential Antitumoral Agents
Volume: 7 Issue: 9
Author(s): Vladimir V. Kouznetsov, Diego R. Merchan Arenas, Francisco Arvelo, Josue S. Bello Forero, Felipe Sojo and Arturo Munoz
Affiliation:
Keywords: Functionalized tetrahydroquinolines, Isoeugenol, Antitumoral agents, Lewis acid-catalyzed imino Diels-Alder reactions, Tetrahydroquinoline compounds, Antimalarial, Antioxidant, Antimycobacterial, Polyfunctionalized quinoline, Anticancer agents, Hemi-synthetic, Synthetiq agents, Imino Diels Alder cycloaddition, Ketimine precursors, HeLa (cervical epithelial carcinoma), Adriamycin, Eugenol, Quinoline derivatives, Cytotoxic activities, Tumor cancer cells, Isatin, Anilines, Reference selectivity index
Abstract: Two series of 17 tetrahydroquinoline compounds (2,4-DAr-THQs and DSQs), in which the 4-methoxy-3- hydroxyphenyl (isovanillin) structural unit is incorporated, were tested for their potential human tumor cell growth inhibitory effect on MCF-7, SKBR-3, PC3, HeLa and for non-tumor cells (primary culture of human dermis fibroblast – control cells) for the first time. The THQ 8 is an interesting model for antitumoral drugs, displaying cytotoxic activity against MCF7, SKBR3 or PC3 (IC50 7.99 - 16.14 μM) with the selectivity index 3.4 for MCF7.
Export Options
About this article
Cite this article as:
V. Kouznetsov Vladimir, R. Merchan Arenas Diego, Arvelo Francisco, S. Bello Forero Josue, Sojo Felipe and Munoz Arturo, 4-Hydroxy-3-methoxyphenyl Substituted 3-methyl-tetrahydroquinoline Derivatives Obtained Through Imino Diels-Alder Reactions as Potential Antitumoral Agents, Letters in Drug Design & Discovery 2010; 7 (9) . https://dx.doi.org/10.2174/157018010792929577
DOI https://dx.doi.org/10.2174/157018010792929577 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ischemic and Oxidative Damage to the Hypothalamus May Be Responsible for Heat Stroke
Current Neuropharmacology Salt: A Review of its Role in Food Science and Public Health
Current Nutrition & Food Science ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Purines as Neurotransmitters and Neuromodulators in Blood Vessels
Current Vascular Pharmacology Minimally-Invasive and Non-Invasive Continuous Glucose Monitoring Systems: Indications, Advantages, Limitations and Clinical Aspects
Current Diabetes Reviews Pharmacogenetically Tailored Treatments for Heart Disease
Current Pharmaceutical Design Sex Differences in Oxidative Stress Biomarkers
Current Drug Targets Novel Promising Therapeutic Agents in Multiple Sclerosis
Recent Patents on Inflammation & Allergy Drug Discovery Efficacy and Cardiovascular Safety of Insulins
Current Drug Safety Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors
Inflammation & Allergy - Drug Targets (Discontinued) Endothelial Dysfunction and Inflammatory Markers of Vascular Disease
Current Vascular Pharmacology Is Formaldehyde the Missing Link in AD Pathology? The Differential Aggregation of Amyloid-Beta with APOE Isoforms In Vitro
Current Alzheimer Research The Role of White Matter Abnormalities in Treatment-Resistant Depression: A Systematic Review
Current Pharmaceutical Design Obesity, Hypertension and Hypercholesterolemia as Risk Factors for Atherosclerosis Leading to Ischemic Events
Current Medicinal Chemistry Drugs of Abuse in Pregnancy, Poor Neonatal Development, and Future Neurodegeneration. Is Oxidative Stress the Culprit?
Current Pharmaceutical Design A Review on the Role of Phytosterols: New Insights Into Cardiovascular Risk
Current Pharmaceutical Design Inhibition of MHC II Gene Transcription by Nitric Oxide and Antioxidants
Current Pharmaceutical Design Beyond Cholesterol Lowering: Pleiotropic Effects of Bile Acid Binding Resins Against Cardiovascular Disease Risk Factors in Patients with Metabolic Syndrome
Current Vascular Pharmacology Telmisartan, its Potential Therapeutic Implications in Cardiometabolic Disorders
Recent Patents on Cardiovascular Drug Discovery Editorial [Hot topic: Current Status of Drug Eluting Stents (Executive Editor: Nicholas Kipshidze)]
Current Pharmaceutical Design